Rosuvastatin 20 mg

DRUG3 trials

Sponsors

Chong Kun Dang Pharmaceutical, Henan Institute of Cardiovascular Epidemiology, Damanhour University

Conditions

DyslipidemiasST Elevation Myocardial Infarction (STEMI)ST-segment Elevation Myocardial Infarction

Phase 1

Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects

CompletedNCT03175835

Chong Kun Dang PharmaceuticalDyslipidemias

Start: 2017-05-08End: 2017-06-19Updated: 2017-07-07

Phase 2

Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients

CompletedNCT05895123

Damanhour UniversityST-segment Elevation Myocardial Infarction

Start: 2021-11-01End: 2023-04-01Updated: 2024-08-01

Phase 4

Effect of Very Early and Rapid Lowering Cholesterol With Evolocumab on Left Ventricular Remodeling in Patients With Anterior STEMI Undergoing Primary PCI

RecruitingNCT05613426

Henan Institute of Cardiovascular EpidemiologyST Elevation Myocardial Infarction (STEMI)

Start: 2023-04-03End: 2026-12-30Target: 330Updated: 2024-12-27

Related Papers

Comparative Study Between the Effects of High Doses of Rosuvastatin and Atorvastatin on Ventricular Remodeling in Patients with ST-Segment Elevation Myocardial Infarction.

2024-09-121 citations